vs
Side-by-side financial comparison of Laser Photonics Corp (LASE) and Ovid Therapeutics Inc. (OVID). Click either name above to swap in a different company.
Laser Photonics Corp is the larger business by last-quarter revenue ($919.3K vs $718.0K, roughly 1.3× Ovid Therapeutics Inc.). On growth, Ovid Therapeutics Inc. posted the faster year-over-year revenue change (844.7% vs 28.3%). Over the past eight quarters, Ovid Therapeutics Inc.'s revenue compounded faster (120.3% CAGR vs -3.9%).
IPG Photonics Corporation is a manufacturer of fiber lasers. IPG Photonics developed and commercialized optical fiber lasers, which are used in a variety of applications including materials processing, medical applications and telecommunications. IPG has manufacturing facilities in the United States, Germany, Russia and Italy.
LASE vs OVID — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $919.3K | $718.0K |
| Net Profit | $-4.7M | — |
| Gross Margin | -20.1% | — |
| Operating Margin | -350.0% | — |
| Net Margin | -506.4% | — |
| Revenue YoY | 28.3% | 844.7% |
| Net Profit YoY | -186.5% | 204.4% |
| EPS (diluted) | $-0.27 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $718.0K | ||
| Q3 25 | $919.3K | $132.0K | ||
| Q2 25 | $2.6M | $6.3M | ||
| Q1 25 | $2.3M | $130.0K | ||
| Q4 24 | $1.3M | $76.0K | ||
| Q3 24 | $716.7K | $173.0K | ||
| Q2 24 | $623.4K | $169.0K | ||
| Q1 24 | $743.0K | $148.0K |
| Q4 25 | — | — | ||
| Q3 25 | $-4.7M | $-12.2M | ||
| Q2 25 | $-1.8M | $-4.7M | ||
| Q1 25 | $-1.7M | $-10.2M | ||
| Q4 24 | $586.4K | — | ||
| Q3 24 | $-1.6M | $-14.0M | ||
| Q2 24 | $-934.3K | $8.5M | ||
| Q1 24 | $-545.7K | $-11.7M |
| Q4 25 | — | — | ||
| Q3 25 | -20.1% | — | ||
| Q2 25 | 53.5% | — | ||
| Q1 25 | 49.8% | — | ||
| Q4 24 | 13.3% | — | ||
| Q3 24 | 85.0% | — | ||
| Q2 24 | 50.6% | — | ||
| Q1 24 | 51.9% | — |
| Q4 25 | — | — | ||
| Q3 25 | -350.0% | -9487.1% | ||
| Q2 25 | -37.0% | -80.9% | ||
| Q1 25 | -68.7% | -9653.8% | ||
| Q4 24 | -255.1% | — | ||
| Q3 24 | -238.0% | -7645.1% | ||
| Q2 24 | -149.4% | -12140.2% | ||
| Q1 24 | -73.8% | -11768.2% |
| Q4 25 | — | — | ||
| Q3 25 | -506.4% | -9210.6% | ||
| Q2 25 | -68.3% | -74.7% | ||
| Q1 25 | -73.4% | -7873.1% | ||
| Q4 24 | 45.7% | — | ||
| Q3 24 | -226.8% | -8096.0% | ||
| Q2 24 | -149.9% | 5042.0% | ||
| Q1 24 | -73.4% | -7901.4% |
| Q4 25 | — | — | ||
| Q3 25 | $-0.27 | — | ||
| Q2 25 | $-0.12 | — | ||
| Q1 25 | $-0.12 | — | ||
| Q4 24 | $0.06 | — | ||
| Q3 24 | $-0.13 | $-0.20 | ||
| Q2 24 | $-0.09 | $0.12 | ||
| Q1 24 | $-0.06 | $-0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.6M | $13.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $4.1M | $130.7M |
| Total Assets | $17.5M | $150.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $13.2M | ||
| Q3 25 | $3.6M | $20.6M | ||
| Q2 25 | $78.5K | $28.4M | ||
| Q1 25 | $179.1K | $21.1M | ||
| Q4 24 | $533.9K | $26.3M | ||
| Q3 24 | $2.1M | $15.0M | ||
| Q2 24 | $2.7M | $29.7M | ||
| Q1 24 | $5.2M | $30.8M |
| Q4 25 | — | $130.7M | ||
| Q3 25 | $4.1M | $44.7M | ||
| Q2 25 | $4.3M | $55.8M | ||
| Q1 25 | $6.8M | $59.3M | ||
| Q4 24 | $10.2M | $68.2M | ||
| Q3 24 | $9.7M | $76.3M | ||
| Q2 24 | $10.3M | $88.9M | ||
| Q1 24 | $12.4M | $78.3M |
| Q4 25 | — | $150.9M | ||
| Q3 25 | $17.5M | $63.8M | ||
| Q2 25 | $14.9M | $77.4M | ||
| Q1 25 | $16.0M | $81.7M | ||
| Q4 24 | $17.2M | $92.2M | ||
| Q3 24 | $10.6M | $102.7M | ||
| Q2 24 | $11.1M | $118.1M | ||
| Q1 24 | $13.6M | $131.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $763.1K | $-38.3M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-38.3M | ||
| Q3 25 | $763.1K | $-12.9M | ||
| Q2 25 | $-1.0M | $-4.8M | ||
| Q1 25 | $-1.2M | $-10.3M | ||
| Q4 24 | $-6.5M | $-56.0M | ||
| Q3 24 | $632.7K | $-15.0M | ||
| Q2 24 | $-2.4M | $-14.3M | ||
| Q1 24 | $-866.3K | $-16.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $-56.0M | ||
| Q3 24 | $589.6K | $-15.0M | ||
| Q2 24 | $-2.4M | $-14.3M | ||
| Q1 24 | $-1.0M | $-16.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -73719.7% | ||
| Q3 24 | 82.3% | -8676.9% | ||
| Q2 24 | -388.0% | -8455.0% | ||
| Q1 24 | -136.9% | -11287.2% |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 93.4% | ||
| Q3 24 | 6.0% | 2.3% | ||
| Q2 24 | 5.1% | 20.1% | ||
| Q1 24 | 20.3% | 12.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -11.11× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -1.67× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
